UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Tracking Triple-negative Breast Cancer Evolution Through Therapy
- Conditions
- Interventions
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 149
- Registration Number
- NCT03077776
- Locations
- 🇫🇷
Centre Leon Bérard, Lyon, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Centre George François Leclerc, Dijon, France
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 269
- Registration Number
- NCT03012581
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus, Villejuif, France
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 334
- Registration Number
- NCT03012620
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus, Villejuif, France
Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 730
- Registration Number
- NCT03013335
- Locations
- 🇫🇷
Centre Francois Baclesse, Caen, France
🇫🇷Centre Georges-Francois Leclerc, Dijon, France
🇫🇷Institut Paoli-Calmettes, Marseille, France
Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
- Conditions
- Interventions
- First Posted Date
- 2016-12-20
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 61
- Registration Number
- NCT02997995
- Locations
- 🇪🇸
HU Arnau de Vilanova, Lleida, Spain
🇫🇷Centre François Baclesse, Caen, France
🇫🇷Institut Jean Godinot, Reims, France
Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 219
- Registration Number
- NCT02980510
- Locations
- 🇫🇷
Institut Sainte Catherine, Avignon, France
🇫🇷Chu Saint Eloi, Montpellier, France
🇫🇷Centre Léon Berard, Lyon, France
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting
- Conditions
- Interventions
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 792
- Registration Number
- NCT02967289
- Locations
- 🇫🇷
Hôpital Saint Antoine, Paris, France
🇨🇦The PEI Cancer Treatment Centre Queen Elizabeth Hospital, Charlottetown, Prince Edward Island, Canada
🇨🇦Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada
Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss
- Conditions
- Interventions
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 11
- Registration Number
- NCT02822482
- Locations
- 🇫🇷
Institut de Cancérologie de l'Ouest, Angers, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Centre Georges François Leclerc, Dijon, France
I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations
- Conditions
- Interventions
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 133
- Registration Number
- NCT02818725
- Locations
- 🇫🇷
Chu de Nimes, Nimes, France
🇫🇷Institut Paoli Calmettes, Marseille, France
🇫🇷Hopital Saint Andre, Bordeaux, France
Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 37
- Registration Number
- NCT02817958
- Locations
- 🇫🇷
ICO-Paul Papin, Angers, France
🇫🇷Chu Lyon Sud, Lyon, France
🇫🇷Chr Besancon, Besançon, France